Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
US9572794B2 · kind B2 · utility
1Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2015 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Aug 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L2205/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention include substituted indole compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.